A Race Against Time: Accelerating the Adoption of GDMT in Heart Failure

Published: 28 May 2024

  • Views:

    Views Icon 4600
  • Likes:

    Heart Icon 7
Average (ratings)
No ratings
Your rating


This symposium emphasises the critical role of accurate and rapid diagnosis in enabling physicians to quickly start guideline-directed medical therapy. Prof Antoni Bayés-Genís (University Hospital Germans Trias i Pujol, Barcelona, ES), Dr Lisa Anderson (St George's Hospital, London, UK) and Dr Stephen Greene (Duke University School of Medicine, Durham, US) discuss and reflect on current guidelines and emerging algorithms, offering insights into the challenges surrounding delays and adoption rates in both community and hospital settings and their profound impact on patient care.

Presented, and recorded, at HFA 2024 in Lisbon, PT

This Satellite Symposium was supported by an unrestricted educational grant from AstraZeneca who had no involvement in the content.

Learning Objectives

  • Recall guideline recommendations for the use of NT-proBNP in heart failure
  • Describe current practices in heart failure diagnosis and the impact on treatment outcomes
  • Develop an optimised approach to the timely diagnosis and management of heart failure

Target Audience

  • Cardiologists
  • Heart Failure Specialists

More from this programme

Part 1

Dr Lisa Anderson introduces the session and launches audience polls  

Part 2

Prof Antoni Bayés-Genís presents and explores the best practices and strategies for implementing GDMT in clinical settings.

Part 3

Dr Lisa Anderson follows up on Prof Bayés-Genís' presentation by highlighting current real-world practices.

Part 4

Dr Stephen Greene examines and highlights the consequences of delayed diagnosis and sub-optimal implementation of GDMT on patient outcomes.

Part 5

The panel further explore the topic, providing insights into the challenges related to delays and adoption rates in both community and hospital settings, and the significant impact on patient care.

Part 6

The session concludes with Prof Antoni Bayés-Genís emphasising the crucial role of early diagnosis in GDMT. 

Faculty Biographies

Antoni Bayés-Genís

Antoni Bayés-Genís

Head of the Cardiology Department

Antoni Bayés-Genís is Head of the Heart Institute at the University Hospital Germans Trias i Pujol in Barcelona, and Professor of Cardiology at the Universitat Autònoma de Barcelona in Barcelona, Spain.

Prof Bayés-Genís is an expert on biomarker, including natriuretic peptides ST2 and neprilysin, having lectured on the subject at numerous international meetings and generated research data that were later included in clinical guidelines.

His research is focused in two main areas, one more clinical and another basic-translational. From the clinical standpoint, he is interested in precision medicine in heart failure, biomarkers, sudden death, devices, new treatment options and epidemiology. At the basic-translational level, he focuses on novel regenerative approaches to rejuvenate the heart, including tissue engineering and cell-derived products.

Prof Bayés-Genís is past President of the Catalan Society of Cardiology, past Editor of Revista Española de Cardiología,…

View full profile
Lisa Anderson

Lisa Anderson

Heart Failure Consultant and Honorary Reader

Dr Lisa Anderson is a Heart Failure Consultant and Honorary Reader in the Cardiovascular Clinical Academic Group, Molecular and Clinical Sciences Research Institute at St George's Hospital in London, UK. Dr Anderson achieved her BSc and MB ChB from Liverpool in 1987 and 1990 respectively. She obtained her MD from Imperial College in 2001 before completing cardiology specialist registrar training at St George's Hospital in 2005.

Dr Anderson was appointed consultant cardiologist in 2005 and was made honorary senior lecturer at St George's University of London in the same year. She has been heart failure lead for the South West London Cardiac and Stroke Network since 2006.

View full profile
Stephen J Greene

Stephen J Greene

Assistant Professor, Division of Cardiology

Dr Greene is a cardiologist with a clinical and research interest in improving quality of care and outcomes for patients with heart failure.  He has been a co-investigator and co-author of multiple national and international heart failure trials studying medical therapies for heart failure. He has also served on leadership committees and led multiple analyses from national and international heart failure registries characterising the quality of heart failure care.  Dr Greene’s collaborative work has led to more than 350 publications in peer-reviewed journals.  

View full profile


You must be to comment. If you are not registered, you can register here.